PPA
CBMG

Parametric Portfolio Associates’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Parametric Portfolio Associates’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-43,748
Closed -$804K – 4117
2020
Q4 		$804K Buy
43,748
+1,382
+3% +$25.2K ﹤0.01% 3160
2020
Q3 		$777K Buy
42,366
+64
+0.2% +$1.08K ﹤0.01% 3061
2020
Q2 		$633K Buy
+42,302
New +$604K ﹤0.01% 3158

Parametric Portfolio Associates's CBMG Position: Q1 2021 in Review

Parametric Portfolio Associates sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 43,748 shares — an estimated $804K sold.

Parametric Portfolio Associates first reported a position in CBMG in Q2 2020 and held it in 3 quarters. The position peaked at $804K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Parametric Portfolio Associates reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 43,748 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $804K.
  • Parametric Portfolio Associates first reported a position in Cellular Biomedicine Group, Inc. in Q2 2020 and held it in 3 quarters.
  • Parametric Portfolio Associates's Cellular Biomedicine Group, Inc. position peaked at $804K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Parametric Portfolio Associates's 13F filing for Q1 2021, filed 17 May 2021.